# Treating Early Stage Diabetic Retinopathy

> **NCT05132660** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **VA Office of Research and Development** · enrollment: 244 (estimated)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Sinemet CR
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05132660
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2022-07-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132660, "Treating Early Stage Diabetic Retinopathy". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05132660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*